Oyster Point Pharma, Inc. Announces Executive Changes
December 07, 2020 at 07:00 am EST
Oyster Point Pharma, Inc. announced the appointment of Marian Macsai, M.D., as Chief Medical Officer, and Eric Carlson, Ph.D., as Chief Scientific Officer, both of whom will join the executive leadership team, effective December 7, 2020.